Santhera Pharmaceuticals announced that Chairman of the Board Elmar Schnee will not stand for re-election at the upcoming Annual General Meeting on June 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.17 CHF | -1.29% | -1.50% | -6.52% |
Apr. 25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
Apr. 25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.52% | 114M | |
+7.91% | 72.81B | |
+12.64% | 9.13B | |
-10.56% | 5.13B | |
+58.79% | 4.99B | |
+4.07% | 3.9B | |
-16.90% | 2.48B | |
+20.84% | 2.42B | |
-26.13% | 2.32B | |
+19.31% | 2.17B |
- Stock Market
- Equities
- SANN Stock
- News Santhera Pharmaceuticals Holding AG
- Santhera Pharmaceuticals Holding AG Announces that Elmar Schnee will not stand for re-election at the upcoming Annual General Meeting